# GAVRETO
> **NDA213721** · New Drug Application · Sponsor: RIGEL PHARMS · Approved 2020-09-04
## Drug
- **FDA Application Number:** NDA213721
- **Application type:** New Drug Application
- **Brand name:** GAVRETO
- **Generic name:** PRALSETINIB
- **Active ingredients:** PRALSETINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RIGEL PHARMS
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2020-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213721)
---
*MORVS · CC0 1.0*